Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins

L. K. Medina-Kauwe, M. Maguire, Noriyuki Kasahara, L. Kedes

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The capsid proteins of adenovirus serotype 5 (Ad5) are key to the virus' highly efficient cell binding and entry mechanism. In particular, the penton base plays a significant role in both viral internalization and endosome penetration. We have produced an adenovirus penton fusion protein (HerPBK10) containing moieties for DNA transport and targeted delivery to breast cancer cells. HerPBK10 binds DNA through a polylysine appendage, while the EGF-like domain of the heregulin-α1 isoform is used as the targeting ligand. This ligand binds with high affinity to HER2/3 or HER2/4 heterodimers, which are overexpressed on certain aggressive breast cancers. In addition, this ligand is rapidly internalized after binding, thus adding to the utility of heregulin for targeting. HerPBK10 binds MDA-MB-453 breast cancer cells in a receptor-specific manner, and mediates the entry of a reporter plasmid in MDA-MB-453 cells in culture. Delivery can be competed by excess heregulin peptide, thus confirming receptor specificity. Importantly, the penton segment appears to contribute significantly to enhanced delivery. Complexes containing HerPBK10 and DNA have been optimized to provide targeted gene delivery to breast cancer cells in vitro. We demonstrate that delivery can be accomplished in the presence of serum, thus suggesting a potential use for in vivo delivery.

Original languageEnglish (US)
Pages (from-to)1753-1761
Number of pages9
JournalGene Therapy
Volume8
Issue number23
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Neuregulin-1
Adenoviridae
Breast Neoplasms
Ligands
Genes
DNA
Proteins
Polylysine
Endosomes
Capsid Proteins
Epidermal Growth Factor
Protein Isoforms
Plasmids
Cell Culture Techniques
Viruses
Peptides
Serogroup
Serum

Keywords

  • Adenovirus
  • Breast cancer
  • Gene delivery
  • Heregulin
  • Nonviral
  • Penton

ASJC Scopus subject areas

  • Genetics

Cite this

Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. / Medina-Kauwe, L. K.; Maguire, M.; Kasahara, Noriyuki; Kedes, L.

In: Gene Therapy, Vol. 8, No. 23, 2001, p. 1753-1761.

Research output: Contribution to journalArticle

Medina-Kauwe, L. K. ; Maguire, M. ; Kasahara, Noriyuki ; Kedes, L. / Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. In: Gene Therapy. 2001 ; Vol. 8, No. 23. pp. 1753-1761.
@article{cf321aa5f88b4ff0a4562838634ff774,
title = "Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins",
abstract = "The capsid proteins of adenovirus serotype 5 (Ad5) are key to the virus' highly efficient cell binding and entry mechanism. In particular, the penton base plays a significant role in both viral internalization and endosome penetration. We have produced an adenovirus penton fusion protein (HerPBK10) containing moieties for DNA transport and targeted delivery to breast cancer cells. HerPBK10 binds DNA through a polylysine appendage, while the EGF-like domain of the heregulin-α1 isoform is used as the targeting ligand. This ligand binds with high affinity to HER2/3 or HER2/4 heterodimers, which are overexpressed on certain aggressive breast cancers. In addition, this ligand is rapidly internalized after binding, thus adding to the utility of heregulin for targeting. HerPBK10 binds MDA-MB-453 breast cancer cells in a receptor-specific manner, and mediates the entry of a reporter plasmid in MDA-MB-453 cells in culture. Delivery can be competed by excess heregulin peptide, thus confirming receptor specificity. Importantly, the penton segment appears to contribute significantly to enhanced delivery. Complexes containing HerPBK10 and DNA have been optimized to provide targeted gene delivery to breast cancer cells in vitro. We demonstrate that delivery can be accomplished in the presence of serum, thus suggesting a potential use for in vivo delivery.",
keywords = "Adenovirus, Breast cancer, Gene delivery, Heregulin, Nonviral, Penton",
author = "Medina-Kauwe, {L. K.} and M. Maguire and Noriyuki Kasahara and L. Kedes",
year = "2001",
doi = "10.1038/sj.gt.3301583",
language = "English (US)",
volume = "8",
pages = "1753--1761",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "23",

}

TY - JOUR

T1 - Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins

AU - Medina-Kauwe, L. K.

AU - Maguire, M.

AU - Kasahara, Noriyuki

AU - Kedes, L.

PY - 2001

Y1 - 2001

N2 - The capsid proteins of adenovirus serotype 5 (Ad5) are key to the virus' highly efficient cell binding and entry mechanism. In particular, the penton base plays a significant role in both viral internalization and endosome penetration. We have produced an adenovirus penton fusion protein (HerPBK10) containing moieties for DNA transport and targeted delivery to breast cancer cells. HerPBK10 binds DNA through a polylysine appendage, while the EGF-like domain of the heregulin-α1 isoform is used as the targeting ligand. This ligand binds with high affinity to HER2/3 or HER2/4 heterodimers, which are overexpressed on certain aggressive breast cancers. In addition, this ligand is rapidly internalized after binding, thus adding to the utility of heregulin for targeting. HerPBK10 binds MDA-MB-453 breast cancer cells in a receptor-specific manner, and mediates the entry of a reporter plasmid in MDA-MB-453 cells in culture. Delivery can be competed by excess heregulin peptide, thus confirming receptor specificity. Importantly, the penton segment appears to contribute significantly to enhanced delivery. Complexes containing HerPBK10 and DNA have been optimized to provide targeted gene delivery to breast cancer cells in vitro. We demonstrate that delivery can be accomplished in the presence of serum, thus suggesting a potential use for in vivo delivery.

AB - The capsid proteins of adenovirus serotype 5 (Ad5) are key to the virus' highly efficient cell binding and entry mechanism. In particular, the penton base plays a significant role in both viral internalization and endosome penetration. We have produced an adenovirus penton fusion protein (HerPBK10) containing moieties for DNA transport and targeted delivery to breast cancer cells. HerPBK10 binds DNA through a polylysine appendage, while the EGF-like domain of the heregulin-α1 isoform is used as the targeting ligand. This ligand binds with high affinity to HER2/3 or HER2/4 heterodimers, which are overexpressed on certain aggressive breast cancers. In addition, this ligand is rapidly internalized after binding, thus adding to the utility of heregulin for targeting. HerPBK10 binds MDA-MB-453 breast cancer cells in a receptor-specific manner, and mediates the entry of a reporter plasmid in MDA-MB-453 cells in culture. Delivery can be competed by excess heregulin peptide, thus confirming receptor specificity. Importantly, the penton segment appears to contribute significantly to enhanced delivery. Complexes containing HerPBK10 and DNA have been optimized to provide targeted gene delivery to breast cancer cells in vitro. We demonstrate that delivery can be accomplished in the presence of serum, thus suggesting a potential use for in vivo delivery.

KW - Adenovirus

KW - Breast cancer

KW - Gene delivery

KW - Heregulin

KW - Nonviral

KW - Penton

UR - http://www.scopus.com/inward/record.url?scp=0035700857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035700857&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3301583

DO - 10.1038/sj.gt.3301583

M3 - Article

C2 - 11803394

AN - SCOPUS:0035700857

VL - 8

SP - 1753

EP - 1761

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 23

ER -